Cargando…

Engineered T Cell Therapy for Cancer in the Clinic

T cells play a key role in cell-mediated immunity, and strategies to genetically modify T cells, including chimeric antigen receptor (CAR) T cell therapy and T cell receptor (TCR) T cell therapy, have achieved substantial advances in the treatment of malignant tumors. In clinical trials, CAR-T cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Lijun, Cao, Yu J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798078/ https://www.ncbi.nlm.nih.gov/pubmed/31681259 http://dx.doi.org/10.3389/fimmu.2019.02250

Ejemplares similares

Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
por: Shafer, Paul, et al.
Publicado: (2022)

Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities
por: Xu, Yifan, et al.
Publicado: (2021)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
por: Wang, Zhidong, et al.
Publicado: (2020)

Engineered T Regulatory Type 1 Cells for Clinical Application
por: Gregori, Silvia, et al.
Publicado: (2018)

Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer Methodology
por: Schmidt, Paula, et al.
Publicado: (2021)

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
por: Meringa, A. D., et al.
Publicado: (2023)

Emerging Strategies in TCR-Engineered T Cells
por: Wei, Fang, et al.
Publicado: (2022)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023)

Engineering cytokines for cancer immunotherapy: a systematic review
por: Fu, Yong, et al.
Publicado: (2023)

Advances in T-Cell Epitope Engineering
por: Pentier, Johanne M., et al.
Publicado: (2013)

Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy
por: Fisher, Jonathan, et al.
Publicado: (2018)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
por: Karvouni, Maria, et al.
Publicado: (2022)

Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2020)

Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
por: Zhao, Qijie, et al.
Publicado: (2021)

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
por: Caratelli, Sara, et al.
Publicado: (2017)

Engineering Specificity and Function of Therapeutic Regulatory T Cells
por: McGovern, Jenny L., et al.
Publicado: (2017)

The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
por: Zheng, Aiping, et al.
Publicado: (2022)

CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
por: Jogalekar, Manasi P., et al.
Publicado: (2022)

Photodynamic therapy improves the clinical efficacy of advanced colorectal cancer and recruits immune cells into the tumor immune microenvironment
por: Gu, Baohong, et al.
Publicado: (2022)

The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
por: Li, Ruonan, et al.
Publicado: (2023)

Current Status of Gene Engineering Cell Therapeutics
por: Saudemont, Aurore, et al.
Publicado: (2018)

Crosstalk of three novel types of programmed cell death defines distinct microenvironment characterization and pharmacogenomic landscape in breast cancer
por: Xu, Lijun
Publicado: (2022)

Effects of chemotherapy and immunotherapy on microbial diversity in TME and engineered bacterial-mediated tumor therapy
por: Zheng, Heng, et al.
Publicado: (2023)

Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials
por: Que, Yimei, et al.
Publicado: (2021)

Engineered M2a macrophages for the treatment of osteoarthritis
por: Liang, Chi, et al.
Publicado: (2022)

Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells
por: Safinia, Niloufar, et al.
Publicado: (2018)

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022)

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
por: Almagro, Juan C., et al.
Publicado: (2018)

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
por: Burger, Michael C., et al.
Publicado: (2019)

M Cells: Intelligent Engineering of Mucosal Immune Surveillance
por: Dillon, Andrea, et al.
Publicado: (2019)

Engineering γδ T Cells: Recognizing and Activating on Their Own Way
por: Dong, Ruoyu, et al.
Publicado: (2022)

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
por: Grunewald, Camilla M., et al.
Publicado: (2021)

Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy
por: Taghikhani, Adeleh, et al.
Publicado: (2020)

Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges
por: Xiao, Bu-Fan, et al.
Publicado: (2021)

Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells
por: Dawson, Nicholas A. J., et al.
Publicado: (2017)

Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments
por: Xu, Xinjie, et al.
Publicado: (2021)

A nomogram model based on the number of examined lymph nodes–related signature to predict prognosis and guide clinical therapy in gastric cancer
por: Li, Huling, et al.
Publicado: (2022)

A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer
por: Zhang, Cheng, et al.
Publicado: (2022)

Cytokines as an important player in the context of CAR-T cell therapy for cancer: Their role in tumor immunomodulation, manufacture, and clinical implications
por: Silveira, Caio Raony Farina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rv6g7cavr4cf9ju50483tu0rsj